- Q1 2024 Galapagos NV Earnings Call TranscriptMay 03, 2024€26.78 (-2.05%)Earnings
- Full Year 2023 Galapagos NV Earnings Call TranscriptFeb 23, 2024€36.28 (+2.14%)Earnings
- Galapagos NV at ASH Meeting & Exposition TranscriptDec 10, 2023
- Q3 2023 Galapagos NV Earnings Call TranscriptNov 03, 2023€34.44 (+5.39%)Earnings
- Half Year 2023 Galapagos NV Earnings Call TranscriptAug 04, 2023€37.24 (-2.23%)Earnings
- Q1 2023 Galapagos NV Earnings Call TranscriptMay 05, 2023€35.65 (-1.71%)Earnings
- Full Year 2022 Galapagos NV Earnings Call TranscriptFeb 24, 2023€35.48 (-3.40%)Earnings
- Galapagos NV at JPMorgan Healthcare Conference TranscriptJan 10, 2023
- Galapagos NV Q3 2022 Earnings Call and R&D Update TranscriptNov 04, 2022€47.58 (+2.08%)Earnings
- Half Year 2022 Galapagos NV Earnings Call TranscriptAug 05, 2022€55.22 (+6.19%)Earnings
- Galapagos NV to Acquire CellPoint BV and Abound Bio Inc M&A Call TranscriptJun 22, 2022
- Q1 2022 Galapagos NV Earnings Call TranscriptMay 06, 2022€56.16 (-2.09%)Earnings
- Q4 2021 Galapagos NV Earnings Call TranscriptFeb 25, 2022€59.14 (+4.27%)Earnings
- Galapagos NV at JPMorgan Healthcare Conference TranscriptJan 13, 2022
- Q3 2021 Galapagos NV Earnings Call TranscriptNov 05, 2021€46.96 (-1.47%)Earnings
- Galapagos NV at Citi Biopharma Conference (Virtual) TranscriptSep 09, 2021
- Q2 2021 Galapagos NV Earnings Call TranscriptAug 06, 2021€51.4 (+0.51%)Earnings
- Q1 2021 Galapagos NV Earnings Call TranscriptMay 07, 2021€61.58 (-1.42%)Earnings
- Q4 2020 Galapagos NV Earnings Call TranscriptFeb 19, 2021€67.2 (-2.61%)Earnings
- Galapagos NV at JPMorgan Healthcare Conference (Virtual) TranscriptJan 14, 2021
- Galapagos NV & Gilead Sciences Inc to Announce New Commercialization and Development Agreement for Rheumatoid Arthritis Treatment Call TranscriptDec 16, 2020
- Q3 2020 Galapagos NV Earnings Call TranscriptNov 06, 2020€106.5 (-2.16%)Earnings
- Galapagos NV Inaugural Toledo Roundtable Presentation (Virtual) TranscriptOct 27, 2020
- H1 2020 Galapagos NV Earnings Call TranscriptAug 07, 2020€161.25 (+2.09%)Earnings
- Q1 2020 Galapagos NV Earnings Call TranscriptMay 08, 2020€206.4 (-1.53%)Earnings
- Q4 2019 Galapagos NV Earnings Call TranscriptFeb 21, 2020€238 (-3.05%)Earnings
- Galapagos NV at JPMorgan Healthcare Conference TranscriptJan 16, 2020
- Galapagos NV R&D Update 2019 TranscriptNov 14, 2019
- Q3 2019 Galapagos NV Earnings Call TranscriptOct 25, 2019€148.65 (+1.88%)Earnings
- Q2 2019 Galapagos NV Earnings Call TranscriptJul 26, 2019€161 (+0.63%)Earnings
- Gilead Sciences Inc and Galapagos NV Enter Into Transformative Research and Development Collaboration Call TranscriptJul 14, 2019
- Q1 2019 Galapagos NV Earnings Call TranscriptApr 26, 2019€99.82 (-0.43%)Earnings
- Q4 2018 Galapagos NV Earnings Call TranscriptFeb 22, 2019€88.8 (-0.07%)Earnings
Q3 2021 Galapagos NV Earnings Call Transcript
Good afternoon, ladies and gentlemen, and welcome to the Galapagos Financial Results Q3 2021 Conference Call. (Operator Instructions) And just to remind you all, this conference call is being recorded.
I would now like to hand over the call to Sofie Van Gijsel. Please go ahead.
Thank you, operator, and welcome all to the audio webcast of Galapagos' Q3 2021 results. I'm Sofie Van Gijsel, Investor Relations, representing the reporting team at Galapagos. A replay of this webcast is accessible by the Galapagos website home page and will be available for download for replay later on today. I would like to remind everyone that we will be making forward-looking statements during today's webcast. These forward-looking statements include remarks concerning future developments of the pipeline and our company and possible changes in the industry and competitive environment. Because these forward-looking statements include risks and uncertainties, Galapagos' actual results may differ materially
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)